Effectiveness of radical stereotactic body radiotherapy for vertebral bone metastasis

Effectiveness of radical stereotactic body radiotherapy for vertebral bone metastasis - SBRT for vertebral bone metastasis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045898

Enrollment

Registered

2021-10-29

Start date

2021-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients with vertebral bone metastasis

Interventions

Effectiveness when irradiating 30 Gy using SBRT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who do not meet the exclusion criteria

Exclusion criteria

Exclusion criteria: Primary lesion is not controlled Metastases to other sites Life prognosis within 1 month I can't communicate Radiation therapy cannot be planned depending on the site of cancer

Design outcomes

Primary

Measure	Time frame
Local control time and overall survival.	—

Secondary

Measure	Time frame
EORTC Grade 3 or higher appearance frequency	—

Countries

Japan

Contacts

Public ContactOsamu Tanaka

Asahi University Hospital Radiation Oncology

c.bluered@gmail.com0583747635

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026